<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04402996</url>
  </required_header>
  <id_info>
    <org_study_id>Sağlık Bilimleri Üniversitesi</org_study_id>
    <nct_id>NCT04402996</nct_id>
  </id_info>
  <brief_title>Meteorin-like Levels in Individuals With Periodontitis</brief_title>
  <official_title>Evaluation of Meteorin-like Levels in Individuals With Healthy and Periodontal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Saglik Bilimleri University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Saglik Bilimleri University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a&#xD;
      role in the pathogenesis of human inflammatory diseases. Metrnl is highly expressed from the&#xD;
      oral mucosa to the esophagus. Periodontitis is a chronic inflammatory disease that can start&#xD;
      with localized inflammatory reactions created by the supporting tissues surrounding the teeth&#xD;
      against microorganisms and then result in loss of teeth. The authors think that Metrnl may&#xD;
      play a role in the periodontitis. The aim of this study is to compare the Metrnl, TNF-α,&#xD;
      IL-1β, TGF-β, IL-10 and VEGF levels of healthy and periodontitis individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodontitis is a destructive chronic inflammatory disease that can start with localized&#xD;
      inflammatory reactions created by the supporting tissues surrounding the teeth against&#xD;
      microorganisms and then result in loss of teeth. Cytokines play an important role in&#xD;
      inflammation that occurs in periodontal disease.&#xD;
&#xD;
      Tumor Necrosis Factor-α (TNF-α), Interleukine -1β ( IL-1β )and Interleukine-6 (IL-6),&#xD;
      Prostaglandin E2 (PGE2) and Interferon gamma (IFN- γ) levels are associated with periodontal&#xD;
      destruction in the pathogenesis of periodontal disease. Vascular endothelial growth factor&#xD;
      (VEGF) are important features of inflammation, wound healing and bone healing. Cytokines such&#xD;
      as Interleukine-10 (IL-10) and transforming growth factor- β (TGF-β) have been reported to&#xD;
      decrease periodontal disease progression rate.&#xD;
&#xD;
      Gingival crevicular fluid shows the cellular response in the periodontium. The most important&#xD;
      host-related ingredients are inflammatory markers, including cytokines, enzymes, and&#xD;
      interleukins. Saliva analysis is used in the diagnosis of systemic conditions as well as in&#xD;
      the diagnosis of oral pathologies.&#xD;
&#xD;
      Meteorin- like (Metrnl) is a protein that plays a role in natural and acquired immune-related&#xD;
      functions and inflammatory responses, and expressed in barrier tissues (skin and mucosa) as&#xD;
      well as various macrophage populations, from dendritic cells and some granulocytes. Metrnl&#xD;
      has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role&#xD;
      in the pathogenesis of human inflammatory diseases. Metrnl, which is highly expressed from&#xD;
      the oral mucosa to the esophagus, may play a role in the onset of periodontitis and an&#xD;
      effective marker in preventing the progression of destruction. We think that Metrnl plays an&#xD;
      important role in periodontitis, an inflammatory disease. The aim of this study is to compare&#xD;
      the Metrnl, TNF-α, IL-1β, TGF-β, IL-10 and VEGF levels of healthy and periodontitis&#xD;
      individuals&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 23, 2019</start_date>
  <completion_date type="Actual">March 3, 2021</completion_date>
  <primary_completion_date type="Actual">March 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>TNF-α</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-1β</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metrnl</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-10 levels</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>saliva VEGF</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TGF-β</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>saliva and serum levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque Index</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>Silness-Löe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing Depth</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>millimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on Probe</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>Ainamo&amp;Bay</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Periodontitis</condition>
  <condition>Gingivitis</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Individuals with Periodontally Healthy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gingivitis</arm_group_label>
    <description>Individuals with Gingival Inflammation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis</arm_group_label>
    <description>Individuals with Periodontitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saliva</intervention_name>
    <description>individuals' saliva samples will be collected and transferred to eppendorf tubes.&#xD;
Until biochemical analysis is carried out will be stored in -80ºC.</description>
    <arm_group_label>Gingivitis</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Periodontitis</arm_group_label>
    <other_name>sampling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gingival crevicular fluid</intervention_name>
    <description>GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes.&#xD;
Until biochemical analysis is carried out will be stored in -80ºC.</description>
    <arm_group_label>Gingivitis</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Periodontitis</arm_group_label>
    <other_name>sampling</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Gingival Crevicular Fluid and Saliva&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals will be divided into three different groups, about 20-25 people in each group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  systemically healthy&#xD;
&#xD;
          -  individuals who does not have a disease under treatment,&#xD;
&#xD;
          -  individuals without regular systemic medication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  receiving periodontal treatment in the last 6 months&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  menopausal or menstrual period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayşe Toraman, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serhat Köseoğlu, assoc prof</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mehmet Sağlam, assoc prof</last_name>
    <role>Study Chair</role>
    <affiliation>Izmir Katip Celebi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Levent Savran, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Izmir Katip Celebi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ebru Sağlam, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ebru Sağlam</name>
      <address>
        <city>İstanbul</city>
        <state>Eyalet/Yerleşke</state>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>October 17, 2021</last_update_submitted>
  <last_update_submitted_qc>October 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Saglik Bilimleri University</investigator_affiliation>
    <investigator_full_name>Ebru SAĞLAM</investigator_full_name>
    <investigator_title>Principal Investigator,Health Sciences University, Dentistry Faculty</investigator_title>
  </responsible_party>
  <keyword>Meteorin-like</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

